Global Clinical Trial Imaging
Global Clinical Trial Imaging

Clinical Trial Imaging Comprehensive Study by Type (Services (Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services), Software), Mode (Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography, Ultrasound, X-Ray, Echocardiography, Others (Magnetic Resonance Elastography, Dual-energy X-ray Absorptiometry)), End User (Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturers, Contract Research Organizations, Academic and Government Research Institutes) Players and Region - Global Market Outlook to 2026

Clinical Trial Imaging Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Mar 2021 Edition 230 Pages 213 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Clinical Trial Imaging Market Scope?
Medical imaging plays a very important role in the process of clinical development of various kinds of novel life science products. Although the medical imaging industry is constantly volatile, the biotechnology and pharmaceutical industries continue to grow. This is due to increased investments in medical imaging companies as well as mergers and acquisitions and the introduction of innovative imaging technologies to support clinical trials for medical devices. However, the high cost of machines and their installation, as well as the large capital required to conduct clinical studies, can stifle the growth of the market. Advances in technology enable significant improvements in the collection, evaluation, and communication of imaging data for clinical trials. Technology-based imaging, particularly image analysis software, offers numerous benefits, including data accuracy, consistency, adaptability, and compliance with clinical trials. For example, image analysis software is implemented in order to manage and control a reader via the analysis of imaging times. The increasing use of technology, along with improved computing power, increases the use of imaging in clinical trials. Clinical trials are thus a very much important part of the process of drug development. However, the cost of conducting these clinical trials has hereby increased in recent years. Therefore, clinical trial imaging is emerging as an alternative measure that can help reduce drug trial costs, thereby improving the clinical trial schedule.

The Clinical Trial Imaging market study is being classified by Type (Services [Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services] and Software) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Players from United States will contribute to the maximum growth of Global Clinical Trial Imaging market throughout the predicted period.

BioClinica, Inc. (United States), Biomedical Systems (United States), Cardiovascular Imaging Technologies (United States), ICON Public Limited Company (Ireland), Intrinsic Imaging, LLC (United States), Medpace (United States), Resonance Health Ltd. (Australia), Navitas Life Sciences (United States), IXICO, PLC (United Kingdom) and PAREXEL International Corporation (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Radiant Sage, LLC (United States), BioTelemetric, Inc. (United States) and WorldCare Clinical, LLC (United States).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Clinical Trial Imaging market by Type, Application and Region.

On the basis of geography, the market of Clinical Trial Imaging has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Influencers and their development strategies
In February 2020, ICON plc had acquired MedPass International, which is a European CRO for medical devices, reimbursement, and regulatory advice. This acquisition would in turn help expand ICON's medical device and diagnostic research services in Europe.
In June 2018, Bioclinica had introduced the SMART technology suite, which is available with the feature of Medical Imaging, Interactive Response Technology (IRT), as well as Electronic Data Capture (EDC) so as to transmit and manage medical image data in accordance with general data protection regulations and all the global requirements, for the purpose of submitting, investigating, and reporting.


Influencing Market Trend
  • The Rising Trend in the Adoption of Innovative Imaging Technologies to Support Clinical Trials for the Medical Device
  • The Rise in the Number of Drug Discoveries
  • The Advancements in Healthcare Infrastructure

Market Drivers
  • The Rising Prevalence of Chronic Diseases
  • The Increasing Geriatric Population
  • Rise in Number of Contract Research Organization

Opportunities
  • The Rise in the Number of Biotechnology and Pharmaceutical Companies
  • Increase in R&D by Growing Pharmaceutical and Biotechnology Industries
  • The Increased Funding and Investment in the Field of Clinical Research and Clinical Trials

Restraints
  • The High Cost of Machinery and Their Installation
  • High Implementation Barriers

Challenges
  • The Enormous Cost of Clinical Trials


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Providers of Clinical Trial Imaging, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.
Report Objectives / Segmentation Covered
By Type
  • Services [Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services]
  • Software
By Mode
  • Computed Tomography
  • Magnetic Resonance Imaging
  • Positron Emission Tomography
  • Ultrasound
  • X-Ray
  • Echocardiography
  • Others [Magnetic Resonance Elastography, Dual-energy X-ray Absorptiometry]

By End User
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Medical Device Manufacturers
  • Contract Research Organizations
  • Academic and Government Research Institutes

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Rising Prevalence of Chronic Diseases
      • 3.2.2. The Increasing Geriatric Population
      • 3.2.3. Rise in Number of Contract Research Organization
    • 3.3. Market Challenges
      • 3.3.1. The Enormous Cost of Clinical Trials
    • 3.4. Market Trends
      • 3.4.1. The Rising Trend in the Adoption of Innovative Imaging Technologies to Support Clinical Trials for the Medical Device
      • 3.4.2. The Rise in the Number of Drug Discoveries
      • 3.4.3. The Advancements in Healthcare Infrastructure
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Clinical Trial Imaging, by Type, Mode, End User and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Clinical Trial Imaging (Value)
      • 5.2.1. Global Clinical Trial Imaging by: Type (Value)
        • 5.2.1.1. Services [Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services]
        • 5.2.1.2. Software
      • 5.2.2. Global Clinical Trial Imaging by: Mode (Value)
        • 5.2.2.1. Computed Tomography
        • 5.2.2.2. Magnetic Resonance Imaging
        • 5.2.2.3. Positron Emission Tomography
        • 5.2.2.4. Ultrasound
        • 5.2.2.5. X-Ray
        • 5.2.2.6. Echocardiography
        • 5.2.2.7. Others [Magnetic Resonance Elastography, Dual-energy X-ray Absorptiometry]
      • 5.2.3. Global Clinical Trial Imaging by: End User (Value)
        • 5.2.3.1. Pharmaceutical Companies
        • 5.2.3.2. Biotechnology Companies
        • 5.2.3.3. Medical Device Manufacturers
        • 5.2.3.4. Contract Research Organizations
        • 5.2.3.5. Academic and Government Research Institutes
      • 5.2.4. Global Clinical Trial Imaging Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Clinical Trial Imaging (Volume)
      • 5.3.1. Global Clinical Trial Imaging by: Type (Volume)
        • 5.3.1.1. Services [Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services]
        • 5.3.1.2. Software
      • 5.3.2. Global Clinical Trial Imaging by: Mode (Volume)
        • 5.3.2.1. Computed Tomography
        • 5.3.2.2. Magnetic Resonance Imaging
        • 5.3.2.3. Positron Emission Tomography
        • 5.3.2.4. Ultrasound
        • 5.3.2.5. X-Ray
        • 5.3.2.6. Echocardiography
        • 5.3.2.7. Others [Magnetic Resonance Elastography, Dual-energy X-ray Absorptiometry]
      • 5.3.3. Global Clinical Trial Imaging by: End User (Volume)
        • 5.3.3.1. Pharmaceutical Companies
        • 5.3.3.2. Biotechnology Companies
        • 5.3.3.3. Medical Device Manufacturers
        • 5.3.3.4. Contract Research Organizations
        • 5.3.3.5. Academic and Government Research Institutes
      • 5.3.4. Global Clinical Trial Imaging Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Clinical Trial Imaging (Price)
      • 5.4.1. Global Clinical Trial Imaging by: Type (Price)
  • 6. Clinical Trial Imaging: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. BioClinica, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Biomedical Systems (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cardiovascular Imaging Technologies (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. ICON Public Limited Company (Ireland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Intrinsic Imaging, LLC (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Medpace (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Resonance Health Ltd. (Australia)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Navitas Life Sciences (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. IXICO, PLC (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. PAREXEL International Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Clinical Trial Imaging Sale, by Type, Mode, End User and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Clinical Trial Imaging (Value)
      • 7.2.1. Global Clinical Trial Imaging by: Type (Value)
        • 7.2.1.1. Services [Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services]
        • 7.2.1.2. Software
      • 7.2.2. Global Clinical Trial Imaging by: Mode (Value)
        • 7.2.2.1. Computed Tomography
        • 7.2.2.2. Magnetic Resonance Imaging
        • 7.2.2.3. Positron Emission Tomography
        • 7.2.2.4. Ultrasound
        • 7.2.2.5. X-Ray
        • 7.2.2.6. Echocardiography
        • 7.2.2.7. Others [Magnetic Resonance Elastography, Dual-energy X-ray Absorptiometry]
      • 7.2.3. Global Clinical Trial Imaging by: End User (Value)
        • 7.2.3.1. Pharmaceutical Companies
        • 7.2.3.2. Biotechnology Companies
        • 7.2.3.3. Medical Device Manufacturers
        • 7.2.3.4. Contract Research Organizations
        • 7.2.3.5. Academic and Government Research Institutes
      • 7.2.4. Global Clinical Trial Imaging Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Clinical Trial Imaging (Volume)
      • 7.3.1. Global Clinical Trial Imaging by: Type (Volume)
        • 7.3.1.1. Services [Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services]
        • 7.3.1.2. Software
      • 7.3.2. Global Clinical Trial Imaging by: Mode (Volume)
        • 7.3.2.1. Computed Tomography
        • 7.3.2.2. Magnetic Resonance Imaging
        • 7.3.2.3. Positron Emission Tomography
        • 7.3.2.4. Ultrasound
        • 7.3.2.5. X-Ray
        • 7.3.2.6. Echocardiography
        • 7.3.2.7. Others [Magnetic Resonance Elastography, Dual-energy X-ray Absorptiometry]
      • 7.3.3. Global Clinical Trial Imaging by: End User (Volume)
        • 7.3.3.1. Pharmaceutical Companies
        • 7.3.3.2. Biotechnology Companies
        • 7.3.3.3. Medical Device Manufacturers
        • 7.3.3.4. Contract Research Organizations
        • 7.3.3.5. Academic and Government Research Institutes
      • 7.3.4. Global Clinical Trial Imaging Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Clinical Trial Imaging (Price)
      • 7.4.1. Global Clinical Trial Imaging by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Clinical Trial Imaging: by Type(USD Million)
  • Table 2. Clinical Trial Imaging Services [Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services] , by Region USD Million (2015-2020)
  • Table 3. Clinical Trial Imaging Software , by Region USD Million (2015-2020)
  • Table 4. Clinical Trial Imaging: by Mode(USD Million)
  • Table 5. Clinical Trial Imaging Computed Tomography , by Region USD Million (2015-2020)
  • Table 6. Clinical Trial Imaging Magnetic Resonance Imaging , by Region USD Million (2015-2020)
  • Table 7. Clinical Trial Imaging Positron Emission Tomography , by Region USD Million (2015-2020)
  • Table 8. Clinical Trial Imaging Ultrasound , by Region USD Million (2015-2020)
  • Table 9. Clinical Trial Imaging X-Ray , by Region USD Million (2015-2020)
  • Table 10. Clinical Trial Imaging Echocardiography , by Region USD Million (2015-2020)
  • Table 11. Clinical Trial Imaging Others [Magnetic Resonance Elastography, Dual-energy X-ray Absorptiometry] , by Region USD Million (2015-2020)
  • Table 12. Clinical Trial Imaging: by End User(USD Million)
  • Table 13. Clinical Trial Imaging Pharmaceutical Companies , by Region USD Million (2015-2020)
  • Table 14. Clinical Trial Imaging Biotechnology Companies , by Region USD Million (2015-2020)
  • Table 15. Clinical Trial Imaging Medical Device Manufacturers , by Region USD Million (2015-2020)
  • Table 16. Clinical Trial Imaging Contract Research Organizations , by Region USD Million (2015-2020)
  • Table 17. Clinical Trial Imaging Academic and Government Research Institutes , by Region USD Million (2015-2020)
  • Table 18. South America Clinical Trial Imaging, by Country USD Million (2015-2020)
  • Table 19. South America Clinical Trial Imaging, by Type USD Million (2015-2020)
  • Table 20. South America Clinical Trial Imaging, by Mode USD Million (2015-2020)
  • Table 21. South America Clinical Trial Imaging, by End User USD Million (2015-2020)
  • Table 22. Brazil Clinical Trial Imaging, by Type USD Million (2015-2020)
  • Table 23. Brazil Clinical Trial Imaging, by Mode USD Million (2015-2020)
  • Table 24. Brazil Clinical Trial Imaging, by End User USD Million (2015-2020)
  • Table 25. Argentina Clinical Trial Imaging, by Type USD Million (2015-2020)
  • Table 26. Argentina Clinical Trial Imaging, by Mode USD Million (2015-2020)
  • Table 27. Argentina Clinical Trial Imaging, by End User USD Million (2015-2020)
  • Table 28. Rest of South America Clinical Trial Imaging, by Type USD Million (2015-2020)
  • Table 29. Rest of South America Clinical Trial Imaging, by Mode USD Million (2015-2020)
  • Table 30. Rest of South America Clinical Trial Imaging, by End User USD Million (2015-2020)
  • Table 31. Asia Pacific Clinical Trial Imaging, by Country USD Million (2015-2020)
  • Table 32. Asia Pacific Clinical Trial Imaging, by Type USD Million (2015-2020)
  • Table 33. Asia Pacific Clinical Trial Imaging, by Mode USD Million (2015-2020)
  • Table 34. Asia Pacific Clinical Trial Imaging, by End User USD Million (2015-2020)
  • Table 35. China Clinical Trial Imaging, by Type USD Million (2015-2020)
  • Table 36. China Clinical Trial Imaging, by Mode USD Million (2015-2020)
  • Table 37. China Clinical Trial Imaging, by End User USD Million (2015-2020)
  • Table 38. Japan Clinical Trial Imaging, by Type USD Million (2015-2020)
  • Table 39. Japan Clinical Trial Imaging, by Mode USD Million (2015-2020)
  • Table 40. Japan Clinical Trial Imaging, by End User USD Million (2015-2020)
  • Table 41. India Clinical Trial Imaging, by Type USD Million (2015-2020)
  • Table 42. India Clinical Trial Imaging, by Mode USD Million (2015-2020)
  • Table 43. India Clinical Trial Imaging, by End User USD Million (2015-2020)
  • Table 44. South Korea Clinical Trial Imaging, by Type USD Million (2015-2020)
  • Table 45. South Korea Clinical Trial Imaging, by Mode USD Million (2015-2020)
  • Table 46. South Korea Clinical Trial Imaging, by End User USD Million (2015-2020)
  • Table 47. Taiwan Clinical Trial Imaging, by Type USD Million (2015-2020)
  • Table 48. Taiwan Clinical Trial Imaging, by Mode USD Million (2015-2020)
  • Table 49. Taiwan Clinical Trial Imaging, by End User USD Million (2015-2020)
  • Table 50. Australia Clinical Trial Imaging, by Type USD Million (2015-2020)
  • Table 51. Australia Clinical Trial Imaging, by Mode USD Million (2015-2020)
  • Table 52. Australia Clinical Trial Imaging, by End User USD Million (2015-2020)
  • Table 53. Rest of Asia-Pacific Clinical Trial Imaging, by Type USD Million (2015-2020)
  • Table 54. Rest of Asia-Pacific Clinical Trial Imaging, by Mode USD Million (2015-2020)
  • Table 55. Rest of Asia-Pacific Clinical Trial Imaging, by End User USD Million (2015-2020)
  • Table 56. Europe Clinical Trial Imaging, by Country USD Million (2015-2020)
  • Table 57. Europe Clinical Trial Imaging, by Type USD Million (2015-2020)
  • Table 58. Europe Clinical Trial Imaging, by Mode USD Million (2015-2020)
  • Table 59. Europe Clinical Trial Imaging, by End User USD Million (2015-2020)
  • Table 60. Germany Clinical Trial Imaging, by Type USD Million (2015-2020)
  • Table 61. Germany Clinical Trial Imaging, by Mode USD Million (2015-2020)
  • Table 62. Germany Clinical Trial Imaging, by End User USD Million (2015-2020)
  • Table 63. France Clinical Trial Imaging, by Type USD Million (2015-2020)
  • Table 64. France Clinical Trial Imaging, by Mode USD Million (2015-2020)
  • Table 65. France Clinical Trial Imaging, by End User USD Million (2015-2020)
  • Table 66. Italy Clinical Trial Imaging, by Type USD Million (2015-2020)
  • Table 67. Italy Clinical Trial Imaging, by Mode USD Million (2015-2020)
  • Table 68. Italy Clinical Trial Imaging, by End User USD Million (2015-2020)
  • Table 69. United Kingdom Clinical Trial Imaging, by Type USD Million (2015-2020)
  • Table 70. United Kingdom Clinical Trial Imaging, by Mode USD Million (2015-2020)
  • Table 71. United Kingdom Clinical Trial Imaging, by End User USD Million (2015-2020)
  • Table 72. Netherlands Clinical Trial Imaging, by Type USD Million (2015-2020)
  • Table 73. Netherlands Clinical Trial Imaging, by Mode USD Million (2015-2020)
  • Table 74. Netherlands Clinical Trial Imaging, by End User USD Million (2015-2020)
  • Table 75. Rest of Europe Clinical Trial Imaging, by Type USD Million (2015-2020)
  • Table 76. Rest of Europe Clinical Trial Imaging, by Mode USD Million (2015-2020)
  • Table 77. Rest of Europe Clinical Trial Imaging, by End User USD Million (2015-2020)
  • Table 78. MEA Clinical Trial Imaging, by Country USD Million (2015-2020)
  • Table 79. MEA Clinical Trial Imaging, by Type USD Million (2015-2020)
  • Table 80. MEA Clinical Trial Imaging, by Mode USD Million (2015-2020)
  • Table 81. MEA Clinical Trial Imaging, by End User USD Million (2015-2020)
  • Table 82. Middle East Clinical Trial Imaging, by Type USD Million (2015-2020)
  • Table 83. Middle East Clinical Trial Imaging, by Mode USD Million (2015-2020)
  • Table 84. Middle East Clinical Trial Imaging, by End User USD Million (2015-2020)
  • Table 85. Africa Clinical Trial Imaging, by Type USD Million (2015-2020)
  • Table 86. Africa Clinical Trial Imaging, by Mode USD Million (2015-2020)
  • Table 87. Africa Clinical Trial Imaging, by End User USD Million (2015-2020)
  • Table 88. North America Clinical Trial Imaging, by Country USD Million (2015-2020)
  • Table 89. North America Clinical Trial Imaging, by Type USD Million (2015-2020)
  • Table 90. North America Clinical Trial Imaging, by Mode USD Million (2015-2020)
  • Table 91. North America Clinical Trial Imaging, by End User USD Million (2015-2020)
  • Table 92. United States Clinical Trial Imaging, by Type USD Million (2015-2020)
  • Table 93. United States Clinical Trial Imaging, by Mode USD Million (2015-2020)
  • Table 94. United States Clinical Trial Imaging, by End User USD Million (2015-2020)
  • Table 95. Canada Clinical Trial Imaging, by Type USD Million (2015-2020)
  • Table 96. Canada Clinical Trial Imaging, by Mode USD Million (2015-2020)
  • Table 97. Canada Clinical Trial Imaging, by End User USD Million (2015-2020)
  • Table 98. Mexico Clinical Trial Imaging, by Type USD Million (2015-2020)
  • Table 99. Mexico Clinical Trial Imaging, by Mode USD Million (2015-2020)
  • Table 100. Mexico Clinical Trial Imaging, by End User USD Million (2015-2020)
  • Table 101. Clinical Trial Imaging Sales: by Type(K Units)
  • Table 102. Clinical Trial Imaging Sales Services [Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services] , by Region K Units (2015-2020)
  • Table 103. Clinical Trial Imaging Sales Software , by Region K Units (2015-2020)
  • Table 104. Clinical Trial Imaging Sales: by Mode(K Units)
  • Table 105. Clinical Trial Imaging Sales Computed Tomography , by Region K Units (2015-2020)
  • Table 106. Clinical Trial Imaging Sales Magnetic Resonance Imaging , by Region K Units (2015-2020)
  • Table 107. Clinical Trial Imaging Sales Positron Emission Tomography , by Region K Units (2015-2020)
  • Table 108. Clinical Trial Imaging Sales Ultrasound , by Region K Units (2015-2020)
  • Table 109. Clinical Trial Imaging Sales X-Ray , by Region K Units (2015-2020)
  • Table 110. Clinical Trial Imaging Sales Echocardiography , by Region K Units (2015-2020)
  • Table 111. Clinical Trial Imaging Sales Others [Magnetic Resonance Elastography, Dual-energy X-ray Absorptiometry] , by Region K Units (2015-2020)
  • Table 112. Clinical Trial Imaging Sales: by End User(K Units)
  • Table 113. Clinical Trial Imaging Sales Pharmaceutical Companies , by Region K Units (2015-2020)
  • Table 114. Clinical Trial Imaging Sales Biotechnology Companies , by Region K Units (2015-2020)
  • Table 115. Clinical Trial Imaging Sales Medical Device Manufacturers , by Region K Units (2015-2020)
  • Table 116. Clinical Trial Imaging Sales Contract Research Organizations , by Region K Units (2015-2020)
  • Table 117. Clinical Trial Imaging Sales Academic and Government Research Institutes , by Region K Units (2015-2020)
  • Table 118. South America Clinical Trial Imaging Sales, by Country K Units (2015-2020)
  • Table 119. South America Clinical Trial Imaging Sales, by Type K Units (2015-2020)
  • Table 120. South America Clinical Trial Imaging Sales, by Mode K Units (2015-2020)
  • Table 121. South America Clinical Trial Imaging Sales, by End User K Units (2015-2020)
  • Table 122. Brazil Clinical Trial Imaging Sales, by Type K Units (2015-2020)
  • Table 123. Brazil Clinical Trial Imaging Sales, by Mode K Units (2015-2020)
  • Table 124. Brazil Clinical Trial Imaging Sales, by End User K Units (2015-2020)
  • Table 125. Argentina Clinical Trial Imaging Sales, by Type K Units (2015-2020)
  • Table 126. Argentina Clinical Trial Imaging Sales, by Mode K Units (2015-2020)
  • Table 127. Argentina Clinical Trial Imaging Sales, by End User K Units (2015-2020)
  • Table 128. Rest of South America Clinical Trial Imaging Sales, by Type K Units (2015-2020)
  • Table 129. Rest of South America Clinical Trial Imaging Sales, by Mode K Units (2015-2020)
  • Table 130. Rest of South America Clinical Trial Imaging Sales, by End User K Units (2015-2020)
  • Table 131. Asia Pacific Clinical Trial Imaging Sales, by Country K Units (2015-2020)
  • Table 132. Asia Pacific Clinical Trial Imaging Sales, by Type K Units (2015-2020)
  • Table 133. Asia Pacific Clinical Trial Imaging Sales, by Mode K Units (2015-2020)
  • Table 134. Asia Pacific Clinical Trial Imaging Sales, by End User K Units (2015-2020)
  • Table 135. China Clinical Trial Imaging Sales, by Type K Units (2015-2020)
  • Table 136. China Clinical Trial Imaging Sales, by Mode K Units (2015-2020)
  • Table 137. China Clinical Trial Imaging Sales, by End User K Units (2015-2020)
  • Table 138. Japan Clinical Trial Imaging Sales, by Type K Units (2015-2020)
  • Table 139. Japan Clinical Trial Imaging Sales, by Mode K Units (2015-2020)
  • Table 140. Japan Clinical Trial Imaging Sales, by End User K Units (2015-2020)
  • Table 141. India Clinical Trial Imaging Sales, by Type K Units (2015-2020)
  • Table 142. India Clinical Trial Imaging Sales, by Mode K Units (2015-2020)
  • Table 143. India Clinical Trial Imaging Sales, by End User K Units (2015-2020)
  • Table 144. South Korea Clinical Trial Imaging Sales, by Type K Units (2015-2020)
  • Table 145. South Korea Clinical Trial Imaging Sales, by Mode K Units (2015-2020)
  • Table 146. South Korea Clinical Trial Imaging Sales, by End User K Units (2015-2020)
  • Table 147. Taiwan Clinical Trial Imaging Sales, by Type K Units (2015-2020)
  • Table 148. Taiwan Clinical Trial Imaging Sales, by Mode K Units (2015-2020)
  • Table 149. Taiwan Clinical Trial Imaging Sales, by End User K Units (2015-2020)
  • Table 150. Australia Clinical Trial Imaging Sales, by Type K Units (2015-2020)
  • Table 151. Australia Clinical Trial Imaging Sales, by Mode K Units (2015-2020)
  • Table 152. Australia Clinical Trial Imaging Sales, by End User K Units (2015-2020)
  • Table 153. Rest of Asia-Pacific Clinical Trial Imaging Sales, by Type K Units (2015-2020)
  • Table 154. Rest of Asia-Pacific Clinical Trial Imaging Sales, by Mode K Units (2015-2020)
  • Table 155. Rest of Asia-Pacific Clinical Trial Imaging Sales, by End User K Units (2015-2020)
  • Table 156. Europe Clinical Trial Imaging Sales, by Country K Units (2015-2020)
  • Table 157. Europe Clinical Trial Imaging Sales, by Type K Units (2015-2020)
  • Table 158. Europe Clinical Trial Imaging Sales, by Mode K Units (2015-2020)
  • Table 159. Europe Clinical Trial Imaging Sales, by End User K Units (2015-2020)
  • Table 160. Germany Clinical Trial Imaging Sales, by Type K Units (2015-2020)
  • Table 161. Germany Clinical Trial Imaging Sales, by Mode K Units (2015-2020)
  • Table 162. Germany Clinical Trial Imaging Sales, by End User K Units (2015-2020)
  • Table 163. France Clinical Trial Imaging Sales, by Type K Units (2015-2020)
  • Table 164. France Clinical Trial Imaging Sales, by Mode K Units (2015-2020)
  • Table 165. France Clinical Trial Imaging Sales, by End User K Units (2015-2020)
  • Table 166. Italy Clinical Trial Imaging Sales, by Type K Units (2015-2020)
  • Table 167. Italy Clinical Trial Imaging Sales, by Mode K Units (2015-2020)
  • Table 168. Italy Clinical Trial Imaging Sales, by End User K Units (2015-2020)
  • Table 169. United Kingdom Clinical Trial Imaging Sales, by Type K Units (2015-2020)
  • Table 170. United Kingdom Clinical Trial Imaging Sales, by Mode K Units (2015-2020)
  • Table 171. United Kingdom Clinical Trial Imaging Sales, by End User K Units (2015-2020)
  • Table 172. Netherlands Clinical Trial Imaging Sales, by Type K Units (2015-2020)
  • Table 173. Netherlands Clinical Trial Imaging Sales, by Mode K Units (2015-2020)
  • Table 174. Netherlands Clinical Trial Imaging Sales, by End User K Units (2015-2020)
  • Table 175. Rest of Europe Clinical Trial Imaging Sales, by Type K Units (2015-2020)
  • Table 176. Rest of Europe Clinical Trial Imaging Sales, by Mode K Units (2015-2020)
  • Table 177. Rest of Europe Clinical Trial Imaging Sales, by End User K Units (2015-2020)
  • Table 178. MEA Clinical Trial Imaging Sales, by Country K Units (2015-2020)
  • Table 179. MEA Clinical Trial Imaging Sales, by Type K Units (2015-2020)
  • Table 180. MEA Clinical Trial Imaging Sales, by Mode K Units (2015-2020)
  • Table 181. MEA Clinical Trial Imaging Sales, by End User K Units (2015-2020)
  • Table 182. Middle East Clinical Trial Imaging Sales, by Type K Units (2015-2020)
  • Table 183. Middle East Clinical Trial Imaging Sales, by Mode K Units (2015-2020)
  • Table 184. Middle East Clinical Trial Imaging Sales, by End User K Units (2015-2020)
  • Table 185. Africa Clinical Trial Imaging Sales, by Type K Units (2015-2020)
  • Table 186. Africa Clinical Trial Imaging Sales, by Mode K Units (2015-2020)
  • Table 187. Africa Clinical Trial Imaging Sales, by End User K Units (2015-2020)
  • Table 188. North America Clinical Trial Imaging Sales, by Country K Units (2015-2020)
  • Table 189. North America Clinical Trial Imaging Sales, by Type K Units (2015-2020)
  • Table 190. North America Clinical Trial Imaging Sales, by Mode K Units (2015-2020)
  • Table 191. North America Clinical Trial Imaging Sales, by End User K Units (2015-2020)
  • Table 192. United States Clinical Trial Imaging Sales, by Type K Units (2015-2020)
  • Table 193. United States Clinical Trial Imaging Sales, by Mode K Units (2015-2020)
  • Table 194. United States Clinical Trial Imaging Sales, by End User K Units (2015-2020)
  • Table 195. Canada Clinical Trial Imaging Sales, by Type K Units (2015-2020)
  • Table 196. Canada Clinical Trial Imaging Sales, by Mode K Units (2015-2020)
  • Table 197. Canada Clinical Trial Imaging Sales, by End User K Units (2015-2020)
  • Table 198. Mexico Clinical Trial Imaging Sales, by Type K Units (2015-2020)
  • Table 199. Mexico Clinical Trial Imaging Sales, by Mode K Units (2015-2020)
  • Table 200. Mexico Clinical Trial Imaging Sales, by End User K Units (2015-2020)
  • Table 201. Clinical Trial Imaging: by Type(USD/Units)
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Company Basic Information, Sales Area and Its Competitors
  • Table 207. Company Basic Information, Sales Area and Its Competitors
  • Table 208. Company Basic Information, Sales Area and Its Competitors
  • Table 209. Company Basic Information, Sales Area and Its Competitors
  • Table 210. Company Basic Information, Sales Area and Its Competitors
  • Table 211. Company Basic Information, Sales Area and Its Competitors
  • Table 212. Clinical Trial Imaging: by Type(USD Million)
  • Table 213. Clinical Trial Imaging Services [Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services] , by Region USD Million (2021-2026)
  • Table 214. Clinical Trial Imaging Software , by Region USD Million (2021-2026)
  • Table 215. Clinical Trial Imaging: by Mode(USD Million)
  • Table 216. Clinical Trial Imaging Computed Tomography , by Region USD Million (2021-2026)
  • Table 217. Clinical Trial Imaging Magnetic Resonance Imaging , by Region USD Million (2021-2026)
  • Table 218. Clinical Trial Imaging Positron Emission Tomography , by Region USD Million (2021-2026)
  • Table 219. Clinical Trial Imaging Ultrasound , by Region USD Million (2021-2026)
  • Table 220. Clinical Trial Imaging X-Ray , by Region USD Million (2021-2026)
  • Table 221. Clinical Trial Imaging Echocardiography , by Region USD Million (2021-2026)
  • Table 222. Clinical Trial Imaging Others [Magnetic Resonance Elastography, Dual-energy X-ray Absorptiometry] , by Region USD Million (2021-2026)
  • Table 223. Clinical Trial Imaging: by End User(USD Million)
  • Table 224. Clinical Trial Imaging Pharmaceutical Companies , by Region USD Million (2021-2026)
  • Table 225. Clinical Trial Imaging Biotechnology Companies , by Region USD Million (2021-2026)
  • Table 226. Clinical Trial Imaging Medical Device Manufacturers , by Region USD Million (2021-2026)
  • Table 227. Clinical Trial Imaging Contract Research Organizations , by Region USD Million (2021-2026)
  • Table 228. Clinical Trial Imaging Academic and Government Research Institutes , by Region USD Million (2021-2026)
  • Table 229. South America Clinical Trial Imaging, by Country USD Million (2021-2026)
  • Table 230. South America Clinical Trial Imaging, by Type USD Million (2021-2026)
  • Table 231. South America Clinical Trial Imaging, by Mode USD Million (2021-2026)
  • Table 232. South America Clinical Trial Imaging, by End User USD Million (2021-2026)
  • Table 233. Brazil Clinical Trial Imaging, by Type USD Million (2021-2026)
  • Table 234. Brazil Clinical Trial Imaging, by Mode USD Million (2021-2026)
  • Table 235. Brazil Clinical Trial Imaging, by End User USD Million (2021-2026)
  • Table 236. Argentina Clinical Trial Imaging, by Type USD Million (2021-2026)
  • Table 237. Argentina Clinical Trial Imaging, by Mode USD Million (2021-2026)
  • Table 238. Argentina Clinical Trial Imaging, by End User USD Million (2021-2026)
  • Table 239. Rest of South America Clinical Trial Imaging, by Type USD Million (2021-2026)
  • Table 240. Rest of South America Clinical Trial Imaging, by Mode USD Million (2021-2026)
  • Table 241. Rest of South America Clinical Trial Imaging, by End User USD Million (2021-2026)
  • Table 242. Asia Pacific Clinical Trial Imaging, by Country USD Million (2021-2026)
  • Table 243. Asia Pacific Clinical Trial Imaging, by Type USD Million (2021-2026)
  • Table 244. Asia Pacific Clinical Trial Imaging, by Mode USD Million (2021-2026)
  • Table 245. Asia Pacific Clinical Trial Imaging, by End User USD Million (2021-2026)
  • Table 246. China Clinical Trial Imaging, by Type USD Million (2021-2026)
  • Table 247. China Clinical Trial Imaging, by Mode USD Million (2021-2026)
  • Table 248. China Clinical Trial Imaging, by End User USD Million (2021-2026)
  • Table 249. Japan Clinical Trial Imaging, by Type USD Million (2021-2026)
  • Table 250. Japan Clinical Trial Imaging, by Mode USD Million (2021-2026)
  • Table 251. Japan Clinical Trial Imaging, by End User USD Million (2021-2026)
  • Table 252. India Clinical Trial Imaging, by Type USD Million (2021-2026)
  • Table 253. India Clinical Trial Imaging, by Mode USD Million (2021-2026)
  • Table 254. India Clinical Trial Imaging, by End User USD Million (2021-2026)
  • Table 255. South Korea Clinical Trial Imaging, by Type USD Million (2021-2026)
  • Table 256. South Korea Clinical Trial Imaging, by Mode USD Million (2021-2026)
  • Table 257. South Korea Clinical Trial Imaging, by End User USD Million (2021-2026)
  • Table 258. Taiwan Clinical Trial Imaging, by Type USD Million (2021-2026)
  • Table 259. Taiwan Clinical Trial Imaging, by Mode USD Million (2021-2026)
  • Table 260. Taiwan Clinical Trial Imaging, by End User USD Million (2021-2026)
  • Table 261. Australia Clinical Trial Imaging, by Type USD Million (2021-2026)
  • Table 262. Australia Clinical Trial Imaging, by Mode USD Million (2021-2026)
  • Table 263. Australia Clinical Trial Imaging, by End User USD Million (2021-2026)
  • Table 264. Rest of Asia-Pacific Clinical Trial Imaging, by Type USD Million (2021-2026)
  • Table 265. Rest of Asia-Pacific Clinical Trial Imaging, by Mode USD Million (2021-2026)
  • Table 266. Rest of Asia-Pacific Clinical Trial Imaging, by End User USD Million (2021-2026)
  • Table 267. Europe Clinical Trial Imaging, by Country USD Million (2021-2026)
  • Table 268. Europe Clinical Trial Imaging, by Type USD Million (2021-2026)
  • Table 269. Europe Clinical Trial Imaging, by Mode USD Million (2021-2026)
  • Table 270. Europe Clinical Trial Imaging, by End User USD Million (2021-2026)
  • Table 271. Germany Clinical Trial Imaging, by Type USD Million (2021-2026)
  • Table 272. Germany Clinical Trial Imaging, by Mode USD Million (2021-2026)
  • Table 273. Germany Clinical Trial Imaging, by End User USD Million (2021-2026)
  • Table 274. France Clinical Trial Imaging, by Type USD Million (2021-2026)
  • Table 275. France Clinical Trial Imaging, by Mode USD Million (2021-2026)
  • Table 276. France Clinical Trial Imaging, by End User USD Million (2021-2026)
  • Table 277. Italy Clinical Trial Imaging, by Type USD Million (2021-2026)
  • Table 278. Italy Clinical Trial Imaging, by Mode USD Million (2021-2026)
  • Table 279. Italy Clinical Trial Imaging, by End User USD Million (2021-2026)
  • Table 280. United Kingdom Clinical Trial Imaging, by Type USD Million (2021-2026)
  • Table 281. United Kingdom Clinical Trial Imaging, by Mode USD Million (2021-2026)
  • Table 282. United Kingdom Clinical Trial Imaging, by End User USD Million (2021-2026)
  • Table 283. Netherlands Clinical Trial Imaging, by Type USD Million (2021-2026)
  • Table 284. Netherlands Clinical Trial Imaging, by Mode USD Million (2021-2026)
  • Table 285. Netherlands Clinical Trial Imaging, by End User USD Million (2021-2026)
  • Table 286. Rest of Europe Clinical Trial Imaging, by Type USD Million (2021-2026)
  • Table 287. Rest of Europe Clinical Trial Imaging, by Mode USD Million (2021-2026)
  • Table 288. Rest of Europe Clinical Trial Imaging, by End User USD Million (2021-2026)
  • Table 289. MEA Clinical Trial Imaging, by Country USD Million (2021-2026)
  • Table 290. MEA Clinical Trial Imaging, by Type USD Million (2021-2026)
  • Table 291. MEA Clinical Trial Imaging, by Mode USD Million (2021-2026)
  • Table 292. MEA Clinical Trial Imaging, by End User USD Million (2021-2026)
  • Table 293. Middle East Clinical Trial Imaging, by Type USD Million (2021-2026)
  • Table 294. Middle East Clinical Trial Imaging, by Mode USD Million (2021-2026)
  • Table 295. Middle East Clinical Trial Imaging, by End User USD Million (2021-2026)
  • Table 296. Africa Clinical Trial Imaging, by Type USD Million (2021-2026)
  • Table 297. Africa Clinical Trial Imaging, by Mode USD Million (2021-2026)
  • Table 298. Africa Clinical Trial Imaging, by End User USD Million (2021-2026)
  • Table 299. North America Clinical Trial Imaging, by Country USD Million (2021-2026)
  • Table 300. North America Clinical Trial Imaging, by Type USD Million (2021-2026)
  • Table 301. North America Clinical Trial Imaging, by Mode USD Million (2021-2026)
  • Table 302. North America Clinical Trial Imaging, by End User USD Million (2021-2026)
  • Table 303. United States Clinical Trial Imaging, by Type USD Million (2021-2026)
  • Table 304. United States Clinical Trial Imaging, by Mode USD Million (2021-2026)
  • Table 305. United States Clinical Trial Imaging, by End User USD Million (2021-2026)
  • Table 306. Canada Clinical Trial Imaging, by Type USD Million (2021-2026)
  • Table 307. Canada Clinical Trial Imaging, by Mode USD Million (2021-2026)
  • Table 308. Canada Clinical Trial Imaging, by End User USD Million (2021-2026)
  • Table 309. Mexico Clinical Trial Imaging, by Type USD Million (2021-2026)
  • Table 310. Mexico Clinical Trial Imaging, by Mode USD Million (2021-2026)
  • Table 311. Mexico Clinical Trial Imaging, by End User USD Million (2021-2026)
  • Table 312. Clinical Trial Imaging Sales: by Type(K Units)
  • Table 313. Clinical Trial Imaging Sales Services [Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services] , by Region K Units (2021-2026)
  • Table 314. Clinical Trial Imaging Sales Software , by Region K Units (2021-2026)
  • Table 315. Clinical Trial Imaging Sales: by Mode(K Units)
  • Table 316. Clinical Trial Imaging Sales Computed Tomography , by Region K Units (2021-2026)
  • Table 317. Clinical Trial Imaging Sales Magnetic Resonance Imaging , by Region K Units (2021-2026)
  • Table 318. Clinical Trial Imaging Sales Positron Emission Tomography , by Region K Units (2021-2026)
  • Table 319. Clinical Trial Imaging Sales Ultrasound , by Region K Units (2021-2026)
  • Table 320. Clinical Trial Imaging Sales X-Ray , by Region K Units (2021-2026)
  • Table 321. Clinical Trial Imaging Sales Echocardiography , by Region K Units (2021-2026)
  • Table 322. Clinical Trial Imaging Sales Others [Magnetic Resonance Elastography, Dual-energy X-ray Absorptiometry] , by Region K Units (2021-2026)
  • Table 323. Clinical Trial Imaging Sales: by End User(K Units)
  • Table 324. Clinical Trial Imaging Sales Pharmaceutical Companies , by Region K Units (2021-2026)
  • Table 325. Clinical Trial Imaging Sales Biotechnology Companies , by Region K Units (2021-2026)
  • Table 326. Clinical Trial Imaging Sales Medical Device Manufacturers , by Region K Units (2021-2026)
  • Table 327. Clinical Trial Imaging Sales Contract Research Organizations , by Region K Units (2021-2026)
  • Table 328. Clinical Trial Imaging Sales Academic and Government Research Institutes , by Region K Units (2021-2026)
  • Table 329. South America Clinical Trial Imaging Sales, by Country K Units (2021-2026)
  • Table 330. South America Clinical Trial Imaging Sales, by Type K Units (2021-2026)
  • Table 331. South America Clinical Trial Imaging Sales, by Mode K Units (2021-2026)
  • Table 332. South America Clinical Trial Imaging Sales, by End User K Units (2021-2026)
  • Table 333. Brazil Clinical Trial Imaging Sales, by Type K Units (2021-2026)
  • Table 334. Brazil Clinical Trial Imaging Sales, by Mode K Units (2021-2026)
  • Table 335. Brazil Clinical Trial Imaging Sales, by End User K Units (2021-2026)
  • Table 336. Argentina Clinical Trial Imaging Sales, by Type K Units (2021-2026)
  • Table 337. Argentina Clinical Trial Imaging Sales, by Mode K Units (2021-2026)
  • Table 338. Argentina Clinical Trial Imaging Sales, by End User K Units (2021-2026)
  • Table 339. Rest of South America Clinical Trial Imaging Sales, by Type K Units (2021-2026)
  • Table 340. Rest of South America Clinical Trial Imaging Sales, by Mode K Units (2021-2026)
  • Table 341. Rest of South America Clinical Trial Imaging Sales, by End User K Units (2021-2026)
  • Table 342. Asia Pacific Clinical Trial Imaging Sales, by Country K Units (2021-2026)
  • Table 343. Asia Pacific Clinical Trial Imaging Sales, by Type K Units (2021-2026)
  • Table 344. Asia Pacific Clinical Trial Imaging Sales, by Mode K Units (2021-2026)
  • Table 345. Asia Pacific Clinical Trial Imaging Sales, by End User K Units (2021-2026)
  • Table 346. China Clinical Trial Imaging Sales, by Type K Units (2021-2026)
  • Table 347. China Clinical Trial Imaging Sales, by Mode K Units (2021-2026)
  • Table 348. China Clinical Trial Imaging Sales, by End User K Units (2021-2026)
  • Table 349. Japan Clinical Trial Imaging Sales, by Type K Units (2021-2026)
  • Table 350. Japan Clinical Trial Imaging Sales, by Mode K Units (2021-2026)
  • Table 351. Japan Clinical Trial Imaging Sales, by End User K Units (2021-2026)
  • Table 352. India Clinical Trial Imaging Sales, by Type K Units (2021-2026)
  • Table 353. India Clinical Trial Imaging Sales, by Mode K Units (2021-2026)
  • Table 354. India Clinical Trial Imaging Sales, by End User K Units (2021-2026)
  • Table 355. South Korea Clinical Trial Imaging Sales, by Type K Units (2021-2026)
  • Table 356. South Korea Clinical Trial Imaging Sales, by Mode K Units (2021-2026)
  • Table 357. South Korea Clinical Trial Imaging Sales, by End User K Units (2021-2026)
  • Table 358. Taiwan Clinical Trial Imaging Sales, by Type K Units (2021-2026)
  • Table 359. Taiwan Clinical Trial Imaging Sales, by Mode K Units (2021-2026)
  • Table 360. Taiwan Clinical Trial Imaging Sales, by End User K Units (2021-2026)
  • Table 361. Australia Clinical Trial Imaging Sales, by Type K Units (2021-2026)
  • Table 362. Australia Clinical Trial Imaging Sales, by Mode K Units (2021-2026)
  • Table 363. Australia Clinical Trial Imaging Sales, by End User K Units (2021-2026)
  • Table 364. Rest of Asia-Pacific Clinical Trial Imaging Sales, by Type K Units (2021-2026)
  • Table 365. Rest of Asia-Pacific Clinical Trial Imaging Sales, by Mode K Units (2021-2026)
  • Table 366. Rest of Asia-Pacific Clinical Trial Imaging Sales, by End User K Units (2021-2026)
  • Table 367. Europe Clinical Trial Imaging Sales, by Country K Units (2021-2026)
  • Table 368. Europe Clinical Trial Imaging Sales, by Type K Units (2021-2026)
  • Table 369. Europe Clinical Trial Imaging Sales, by Mode K Units (2021-2026)
  • Table 370. Europe Clinical Trial Imaging Sales, by End User K Units (2021-2026)
  • Table 371. Germany Clinical Trial Imaging Sales, by Type K Units (2021-2026)
  • Table 372. Germany Clinical Trial Imaging Sales, by Mode K Units (2021-2026)
  • Table 373. Germany Clinical Trial Imaging Sales, by End User K Units (2021-2026)
  • Table 374. France Clinical Trial Imaging Sales, by Type K Units (2021-2026)
  • Table 375. France Clinical Trial Imaging Sales, by Mode K Units (2021-2026)
  • Table 376. France Clinical Trial Imaging Sales, by End User K Units (2021-2026)
  • Table 377. Italy Clinical Trial Imaging Sales, by Type K Units (2021-2026)
  • Table 378. Italy Clinical Trial Imaging Sales, by Mode K Units (2021-2026)
  • Table 379. Italy Clinical Trial Imaging Sales, by End User K Units (2021-2026)
  • Table 380. United Kingdom Clinical Trial Imaging Sales, by Type K Units (2021-2026)
  • Table 381. United Kingdom Clinical Trial Imaging Sales, by Mode K Units (2021-2026)
  • Table 382. United Kingdom Clinical Trial Imaging Sales, by End User K Units (2021-2026)
  • Table 383. Netherlands Clinical Trial Imaging Sales, by Type K Units (2021-2026)
  • Table 384. Netherlands Clinical Trial Imaging Sales, by Mode K Units (2021-2026)
  • Table 385. Netherlands Clinical Trial Imaging Sales, by End User K Units (2021-2026)
  • Table 386. Rest of Europe Clinical Trial Imaging Sales, by Type K Units (2021-2026)
  • Table 387. Rest of Europe Clinical Trial Imaging Sales, by Mode K Units (2021-2026)
  • Table 388. Rest of Europe Clinical Trial Imaging Sales, by End User K Units (2021-2026)
  • Table 389. MEA Clinical Trial Imaging Sales, by Country K Units (2021-2026)
  • Table 390. MEA Clinical Trial Imaging Sales, by Type K Units (2021-2026)
  • Table 391. MEA Clinical Trial Imaging Sales, by Mode K Units (2021-2026)
  • Table 392. MEA Clinical Trial Imaging Sales, by End User K Units (2021-2026)
  • Table 393. Middle East Clinical Trial Imaging Sales, by Type K Units (2021-2026)
  • Table 394. Middle East Clinical Trial Imaging Sales, by Mode K Units (2021-2026)
  • Table 395. Middle East Clinical Trial Imaging Sales, by End User K Units (2021-2026)
  • Table 396. Africa Clinical Trial Imaging Sales, by Type K Units (2021-2026)
  • Table 397. Africa Clinical Trial Imaging Sales, by Mode K Units (2021-2026)
  • Table 398. Africa Clinical Trial Imaging Sales, by End User K Units (2021-2026)
  • Table 399. North America Clinical Trial Imaging Sales, by Country K Units (2021-2026)
  • Table 400. North America Clinical Trial Imaging Sales, by Type K Units (2021-2026)
  • Table 401. North America Clinical Trial Imaging Sales, by Mode K Units (2021-2026)
  • Table 402. North America Clinical Trial Imaging Sales, by End User K Units (2021-2026)
  • Table 403. United States Clinical Trial Imaging Sales, by Type K Units (2021-2026)
  • Table 404. United States Clinical Trial Imaging Sales, by Mode K Units (2021-2026)
  • Table 405. United States Clinical Trial Imaging Sales, by End User K Units (2021-2026)
  • Table 406. Canada Clinical Trial Imaging Sales, by Type K Units (2021-2026)
  • Table 407. Canada Clinical Trial Imaging Sales, by Mode K Units (2021-2026)
  • Table 408. Canada Clinical Trial Imaging Sales, by End User K Units (2021-2026)
  • Table 409. Mexico Clinical Trial Imaging Sales, by Type K Units (2021-2026)
  • Table 410. Mexico Clinical Trial Imaging Sales, by Mode K Units (2021-2026)
  • Table 411. Mexico Clinical Trial Imaging Sales, by End User K Units (2021-2026)
  • Table 412. Clinical Trial Imaging: by Type(USD/Units)
  • Table 413. Research Programs/Design for This Report
  • Table 414. Key Data Information from Secondary Sources
  • Table 415. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Clinical Trial Imaging: by Type USD Million (2015-2020)
  • Figure 5. Global Clinical Trial Imaging: by Mode USD Million (2015-2020)
  • Figure 6. Global Clinical Trial Imaging: by End User USD Million (2015-2020)
  • Figure 7. South America Clinical Trial Imaging Share (%), by Country
  • Figure 8. Asia Pacific Clinical Trial Imaging Share (%), by Country
  • Figure 9. Europe Clinical Trial Imaging Share (%), by Country
  • Figure 10. MEA Clinical Trial Imaging Share (%), by Country
  • Figure 11. North America Clinical Trial Imaging Share (%), by Country
  • Figure 12. Global Clinical Trial Imaging: by Type K Units (2015-2020)
  • Figure 13. Global Clinical Trial Imaging: by Mode K Units (2015-2020)
  • Figure 14. Global Clinical Trial Imaging: by End User K Units (2015-2020)
  • Figure 15. South America Clinical Trial Imaging Share (%), by Country
  • Figure 16. Asia Pacific Clinical Trial Imaging Share (%), by Country
  • Figure 17. Europe Clinical Trial Imaging Share (%), by Country
  • Figure 18. MEA Clinical Trial Imaging Share (%), by Country
  • Figure 19. North America Clinical Trial Imaging Share (%), by Country
  • Figure 20. Global Clinical Trial Imaging: by Type USD/Units (2015-2020)
  • Figure 21. Global Clinical Trial Imaging share by Players 2020 (%)
  • Figure 22. Global Clinical Trial Imaging share by Players (Top 3) 2020(%)
  • Figure 23. Global Clinical Trial Imaging share by Players (Top 5) 2020(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. BioClinica, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. BioClinica, Inc. (United States) Revenue: by Geography 2020
  • Figure 27. Biomedical Systems (United States) Revenue, Net Income and Gross profit
  • Figure 28. Biomedical Systems (United States) Revenue: by Geography 2020
  • Figure 29. Cardiovascular Imaging Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 30. Cardiovascular Imaging Technologies (United States) Revenue: by Geography 2020
  • Figure 31. ICON Public Limited Company (Ireland) Revenue, Net Income and Gross profit
  • Figure 32. ICON Public Limited Company (Ireland) Revenue: by Geography 2020
  • Figure 33. Intrinsic Imaging, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 34. Intrinsic Imaging, LLC (United States) Revenue: by Geography 2020
  • Figure 35. Medpace (United States) Revenue, Net Income and Gross profit
  • Figure 36. Medpace (United States) Revenue: by Geography 2020
  • Figure 37. Resonance Health Ltd. (Australia) Revenue, Net Income and Gross profit
  • Figure 38. Resonance Health Ltd. (Australia) Revenue: by Geography 2020
  • Figure 39. Navitas Life Sciences (United States) Revenue, Net Income and Gross profit
  • Figure 40. Navitas Life Sciences (United States) Revenue: by Geography 2020
  • Figure 41. IXICO, PLC (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 42. IXICO, PLC (United Kingdom) Revenue: by Geography 2020
  • Figure 43. PAREXEL International Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 44. PAREXEL International Corporation (United States) Revenue: by Geography 2020
  • Figure 45. Global Clinical Trial Imaging: by Type USD Million (2021-2026)
  • Figure 46. Global Clinical Trial Imaging: by Mode USD Million (2021-2026)
  • Figure 47. Global Clinical Trial Imaging: by End User USD Million (2021-2026)
  • Figure 48. South America Clinical Trial Imaging Share (%), by Country
  • Figure 49. Asia Pacific Clinical Trial Imaging Share (%), by Country
  • Figure 50. Europe Clinical Trial Imaging Share (%), by Country
  • Figure 51. MEA Clinical Trial Imaging Share (%), by Country
  • Figure 52. North America Clinical Trial Imaging Share (%), by Country
  • Figure 53. Global Clinical Trial Imaging: by Type K Units (2021-2026)
  • Figure 54. Global Clinical Trial Imaging: by Mode K Units (2021-2026)
  • Figure 55. Global Clinical Trial Imaging: by End User K Units (2021-2026)
  • Figure 56. South America Clinical Trial Imaging Share (%), by Country
  • Figure 57. Asia Pacific Clinical Trial Imaging Share (%), by Country
  • Figure 58. Europe Clinical Trial Imaging Share (%), by Country
  • Figure 59. MEA Clinical Trial Imaging Share (%), by Country
  • Figure 60. North America Clinical Trial Imaging Share (%), by Country
  • Figure 61. Global Clinical Trial Imaging: by Type USD/Units (2021-2026)
Some of the key companies/manufacturers profiled in the report
  • BioClinica, Inc. (United States)
  • Biomedical Systems (United States)
  • Cardiovascular Imaging Technologies (United States)
  • ICON Public Limited Company (Ireland)
  • Intrinsic Imaging, LLC (United States)
  • Medpace (United States)
  • Resonance Health Ltd. (Australia)
  • Navitas Life Sciences (United States)
  • IXICO, PLC (United Kingdom)
  • PAREXEL International Corporation (United States)
Additional players considered in the study are as follows:
Radiant Sage, LLC (United States) , BioTelemetric, Inc. (United States) , WorldCare Clinical, LLC (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation